Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
Handy A, Banerjee A, Wood AM, Dale C, Sudlow CLM, Tomlinson C, Bean D, Thygesen JH, Mizani MA, Katsoulis M, Takhar R, Hollings S, Denaxas S, Walker V, Dobson R, Sofat R; CVD-COVID-UK Consortium.
Handy A, et al. Among authors: denaxas s.
Heart. 2022 May 25;108(12):923-931. doi: 10.1136/heartjnl-2021-320325.
Heart. 2022.
PMID: 35273122
Free PMC article.